chevron_leftBack
As of 24 April 2025, Qingdao Baheal Medical INC. has a market cap of $1.42B USD, ranking #6642 globally and #1623 in China. It ranks #630 in the Healthcare sector, and #21 in the Medical Distribution industry.
Key Stats
Market Cap
$1.42BUSD
10.34B CNY
Enterprise Value
$1.55BUSD
11.31B CNY
Revenue (TTM)
$1.04BUSD
7.56B CNY
EBITDA (TTM)
$132.86MUSD
968.17M CNY
Net Income (TTM)
$90.07MUSD
656.31M CNY
EBITDA Margin
13%
Profit Margin
8.7%
PE Ratio
14.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Distribution
CEO
Gang Fu
open_in_new
Employees
2,642
Founded
2005
Website
bahealpharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.1% | -0.5% | -8.5% | -15% | -30% | -41% |
Upcoming Earnings
Earnings Date
Thu, Apr 24
Today
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
301015
青岛百洋医药股份有限公司 Class A
ISIN: CNE100004LR8
Shares Out.:
Shares Outstanding:
525.619M1
Shares Float:
452.356M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
19.64 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Qingdao Baheal Medical INC.
Qingdao Baheal Medical INC. engages in research and development, production, and sale of pharmaceutical products. The company offers vitamin D calcium chewable tablets. The company was founded in 2005 and is based in Qingdao, China.
